Trial Details
COMPLETEDBasic Information
| Clinical ID | c4697 |
|---|---|
| Identifier | NCT00105300 |
| Trial Title | Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Adalimumab |
Participant Information
| Sponsor | Abbott |
|---|---|
| City | Huntsville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2004-10 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |